top 20 stocks to invest in


AT&T’s (NYSE:T) roll-out of the DirecTV Now service has been greeted by enthusiasm by some (me) and skepticism by others. The later camp notes that margins, at least on the introductory pricing, are likely to be slim and may cannibalize the company’s traditional DirecTV product offering.

In my mind, the DirecTV Now product was a forward-looking master stroke that begins to create an ecosystem that reduces churn, creates longer-term synergies and, in an era of increasing wireless (and content) choices, creates a compelling bundle that appeals to all (but millennials in particular). In last months, ” AT&T’s DirecTV Now: The Unexpected Fall Hit”, the surprisingly positive initial response of consumers is discussed.

top 20 stocks to invest in: Finisar Corporation(FNSR)


Advisors’ Opinion:

  • [By Lisa Levin]

    Finisar Corporation (NASDAQ: FNSR) shares were also up, gaining 18 percent to $16.70 after the company reported upbeat Q3 earnings.

    Equities Trading DOWN

  • [By Dan Caplinger]

    Friday was a good day on Wall Street, as the stock market responded favorably to encouraging news on the employment front. The U.S. unemployment rate dropped on fairly strong job creation during the month of February, and that helped push the Dow, S&P 500, and Nasdaq Composite to modest gains of roughly between a quarter percent and a half percent. Yet even with a positive mood among market participants, some stocks weren’t able to participate in the end-of-week rally. Finisar (NASDAQ:FNSR), Zumiez (NASDAQ:ZUMZ), and Winnebago Industries (NYSE:WGO) were among the worst performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so poorly.

  • [By Lisa Levin]

    Shares of Finisar Corporation (NASDAQ: FNSR) got a boost, shooting up 28 percent to $24.69 following announcement of a $390 million award from Apple Inc. (NASDAQ: AAPL).

  • [By Lisa Levin]

    Finisar Corporation (NASDAQ: FNSR) shares dropped 21 percent to $27.46 after the company reported weaker-than-expected results for its third quarter and issued disappointing forecast for the current quarter.

  • [By Anders Bylund]

    Shares of Finisar (NASDAQ:FNSR) rose 13.2% in February 2017, according to data from S&P Global Market Intelligence.


    So what

    The bulk of Finisar’s February surge started when chief rival Lumentum (NASDAQ:LITE) delivered a strong earnings surprise, followed by several rosy analyst reviews. Lumentum’s solid results led investors to optimistic conclusions about the many target markets these two companies have in common, and Finisar’s gains nearly matched Lumentum’s post-earnings surge.

  • [By Lisa Levin]

    Shares of Foresight Autonomous Holdings ADR (NASDAQ: FNSR) were down 8 percent to $4.34. On Friday, Foresight posted Q3 non-GAAP net loss of $2,086,000, versus a year-ago non-GAAP net loss of $879,000.

top 20 stocks to invest in: Biogen Idec Inc(BIIB)


Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Breakups have the potential to create a lot of value. Just look at what Biogen (BIIB) did with its hemophilia franchise. Spun out as Bioverativ (BIVV) , shares started trading earlier this year. The stock has climbed some 23% on seemingly no news, Cramer noted.

  • [By Chris Lange]

    Biogen Inc. (NASDAQ: BIIB) had its short interest increase to 2.63 million shares from the previous 2.36 million. The stock closed Friday at $305.20, within a 52-week range of $223.02 to $333.65.

  • [By Brian Orelli]

    While that’s fine for clinical trials, it may make it difficult for Ionis’ drugs to compete with drugs that work as well but don’t have side effects that need to be monitored. Of course, for Spinraza, which Biogen (NASDAQ:BIIB) and Ionis recently got approved for spinal muscular atrophy, side effects aren’t an issue because there aren’t any other treatment options at the moment.

  • [By Ben Levisohn]

    Biogen (BIIB) has dropped 2.2% to $286.16 after getting cut to Market Perform from Outperform at Leerink, and to Equal Weight from Overweight at Morgan Stanley.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Thursday was Biogen Inc. (NASDAQ: BIIB) which traded down 4.6% at $279.08. The stocks 52-week range is $223.02 to $333.65. Volume was 3.4 million versus the daily average of 1.6 million shares.

  • [By George Budwell]

    Shares of theDanish drugmaker Forward Pharma A/S (NASDAQ:FWP) gained 48.2% yesterday as the result of a settlement and licensing deal with Biogen (NASDAQ:BIIB)involving an ongoing patent dispute over the multiple sclerosis drug Tecfidera. Per the terms of the deal, Biogen will fork overa non-refundable$1.25 billion licensing fee, and possibly pay 10% to 20% royalties on Tecfidera’snet sales to Forward starting in 2021.

top 20 stocks to invest in: Dave & Buster's Entertainment, Inc.(PLAY)


Advisors’ Opinion:

  • [By Peter Graham]

    Small cap restaurant and entertainment stockDave & Busters Entertainment Inc (NASDAQ: PLAY) reported Q3 2017 earnings after the Tuesday close that exceeded Wall Street expectations plus the Company announced a new smaller store format. Total revenues increased 9.3% to $250.0 million. Across all stores, Food and Beverage revenues increased 6.3% to $107.7 million and Amusement and Other revenues increased 11.8% to $142.3 million asFood and Beverage represented 43.1% of total revenues while Amusements and Other represented 56.9% of total revenues. In last years third quarter, Food & Beverage represented 44.3% of total revenues while Amusements and Other represented 55.7% of total revenues.

  • [By Rich Duprey]

    Yet as much as staying home and watching movies or television might be impacting Buffalo Wild Wings’ bottom line, it’s clear other factors are also at play, because where the beer-and-wings joint continues to report falling sales, rival Dave & Buster’s Entertainment(NASDAQ:PLAY) is see strong growth.

  • [By Lisa Levin]

    Dave & Buster's Entertainment, Inc. (NASDAQ: PLAY) was down, falling around 10 percent to $52.38. Dave & Buster's posted upbeat earnings for its second quarter, while sales missed expectations. The company also cut its comparable-store sales forecast for its fiscal year.

  • [By Lisa Levin]

    Dave & Buster's Entertainment, Inc. (NASDAQ: PLAY) shares were also up, gaining 17 percent to $56.39 after the company reported stronger-than-expected results for its third quarter and boosted its full year net income guidance.

  • [By Peter Graham]

    After the market closed yesterday, small cap restaurant and entertainment stockDave & Busters Entertainment Inc (NASDAQ: PLAY) reported Q4 2016 earnings with shares falling by mid single digit percentagesin after hours trading. The Company apparently beat expectations on earnings, but fell short of expectations for comps. Likewise, the stock has already had a very good run meaning expectations were super high.Take a look at the following long term chart which shows Dave & Busters Entertainmentsshare performanceascompared to potential peers such as Buffalo Wild Wings (NASDAQ: BWLD) and upscale gentlemen’s clubs and restaurant ownerRCI Hospitality Holdings, Inc (NASDAQ: RICK):

  • [By WWW.THESTREET.COM]

    All is not lost for retail, however. Cramer continued to recommend the closeout and discount chains like TJX Stores (TJX) , Ollie’s Bargain Outlet (OLLI) and Burlington Stores (BURL) . He was also bullish on those who cater to the millennials, like Six Flags (SIX) , Dave & Busters (PLAY) and Foot Locker (FL) , where trying on shoes never seems to go out of style.

top 20 stocks to invest in: Valmont Industries, Inc.(VMI)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    In the Lightning Round, Cramer was bullish on Masco (MAS) , American Electric Power (AEP) and Valmont Industries (VMI) .

    Cramer was bearish on Wisconsin Energy (WEC) .

top 20 stocks to invest in: Senior Housing Properties Trust(SNH)

Advisors’ Opinion:

  • [By Matthew Frankel]

    Healthcare real estate is just as defensive of an investment as net-lease retail, and has even more growth potential in the years ahead. One beaten-down healthcare REIT that I have my eye on in 2017 is Senior Housing Properties Trust (NASDAQ:SNH).

Leave a Reply

Your email address will not be published. Required fields are marked *